As the precision medicine approach to drug development faces a critical time in it’s history, the 7th Annual World CDx Boston Summit will once again provide the industry-defining platform for drug, diagnostic and tech developers to accelerate the progression of biomarker-driven therapies to stratified patient populations.
In 2016, World CDx Boston will answer a multitude of questions and pressing challenges, such as, the impact of complementary diagnostics and biomarkers in immuno-oncology, the growing importance of liquid biopsies in clinical trials and patient testing and the constantly changing regulatory and reimbursement environment that is stifling commercialization success. Join World CDx Boston as it once again unites the collaborative multi-stakeholder ecosystem that is pioneering the next generation of precision therapies & diagnostics to market.
“World CDx was a fantastic event both in terms of the science and the networking opportunities."
- Oscar Puig, Biomarker Leader, Oncology, Roche